Inizio Information

Inizio is a scaled commercialization platform that unlocks, activates and optimizes value for pharma and biopharma at each pivotal moment. We apply our collective expertise to our clients’ most complex challenges, helping them make the right strategic choices to unlock the full value of their healthcare innovation – so more people get the medicines they need, faster. With over 11,700 empowered experts across 50 countries, we continue to achieve meaningful results: 📈 100% of top 20 pharma as clients (based on worldwide sales) 📈 328 products where we have supported in early-stage pre-commercialization (2021-2022) 📈 50% of all US product launches supported (2021-2022) 📈 95% of top products supported in 2022 (by revenue generation) To find out more about Inizio, visit our website below.